We unite European ALK positive cancer patients towards a cure
Collaborate with us
We are ALK Positive Europe, a non-profit organization connecting patient communities, associations, and advocacy groups across Europe. Our goal is to improve the quality of life for ALK-positive patients and turn a terminal illness into a chronic and hopefully curable disease. We work to expand access to cutting-edge healthcare, clinical trials, drugs, and therapies for European patients.
We are the largest ALK-positive patient community in Europe, with 13 members representing 1700 patients and caregivers.
We are a patient-driven voice and advocacy group driving awareness, advocacy and research supporting improved therapeutics aiming to change the future of ALK-positive cancer.
APEU concentrates on the challenges in Europe.
APEU is an umbrella association and serves as a platform where representatives from member countries come together to address the specific needs of European ALK Positive patients.
ALK Positive Europe is not a support group, but we connect you with organizations and ambassadors in your country who offer support to ALK-positive cancer patients.
What is ALK+ cancer?
ALK-positive cancer is caused by alterations of the anaplastic lymphoma kinase (ALK) gene, leading to uncontrolled cell replication and survival.
We unite European ALK-positive cancer patients towards a cure.
Members of ALK Positive Europe are part of a dedicated community working to improve the lives of ALK-positive cancer patients across Europe. Together, we collaborate, share resources, and amplify our collective voice to advance research, raise awareness, and advocate for better access to treatments and care.
